Roche Media Nov 18, 2025 Roche reports positive Phase III data of giredestrant for breast cancer - Clinical Trials Arena #Phase III #Clinical Trials
Roche Media Nov 11, 2025 Roche sizes up first BTK inhibitor approval on Phase III MS victory - Clinical Trials Arena #Phase III #Clinical Trials
Roche Media Nov 3, 2025 Roche’s Phase III trial of Gazyva/Gazyvaro for SLE meets primary endpoint - Clinical Trials Arena #Phase III #III trial
Thermo Fisher Oct 29, 2025 Thermo Fisher to buy Clario for $8.8bn - Clinical Trials Arena #Clinical Trials #Trials Arena